Morgan Stanley upgraded Intuitive Surgical and Stryker, forecasting strong demand and a $1 billion-$2 billion backlog. Analyst downgraded Nevro and Glaukos due to weak demand and valuation concerns.
We came across a bullish thesis on Intuitive Surgical, Inc. (ISRG) on Substack by Kontra Investment Xchange. In this article, ...
Shares of Intuitive Surgical Inc. ISRG advanced 1.52% to $549.95 Wednesday, on what proved to be an all-around favorable ...
Stifel raised the firm’s price target on Intuitive Surgical (ISRG) to $610 from $525 and keeps a Buy rating on the shares. After having had ...
I don't think a monopoly market is healthy,” said CMR co-founder Mark Slack, discussing robotic surgery pioneer Intuitive ...
Intuitive Surgical and its Da Vinci surgical robot have been demonstrating how technology can improve surgical outcomes.
Intuitive Surgical, Inc. (ISRG) closed at $549.80 in the latest trading session, marking a +1.49% move from the prior day. The stock's performance was ahead of the S&P 500's daily gain of 0.61%. On ...
The stock's fall snapped a two-day winning streak.
Intuitive Surgical's da Vinci systems revolutionize minimally invasive surgery, offering superior precision, dexterity, and visualization, leading to better patient outcomes and efficiency.
Intuitive Surgical has become a leader for numerous procedures, and we expect it to continue its growth. The company is seeing double-digit growth both in systems and consumables driving revenue.
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...